Searle secures DRAP’s approval for Denosumab biosimilar injections
Company prepares commercial rollout of 60mg and 120mg doses for osteoporosis and oncology care
Seasonal flu pushing up rates of Arinac Forte, Panadol CF
KARACHI: As seasonal flu sets in, demand has surged for Arinac Forte and Panadol CF , used for cold and flu and witnessed...
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Fate of Pfizer’s consumer business in spotlight after Merck sells its unit
NEW YORK: With the sale of Merck's consumer healthcare business to Procter & Gamble, the spotlight now shifts to the fate of Pfizer's consumer...
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
Is Treet Corporation Pakistan’s next big conglomerate?
Syed Sheharyar Ali is now the fourth generation of his family to be a major business owner in the region that is...
DPCA uncovers tax evasion in import of cancer drug
KARACHI: A case of tax evasion in import of cancer drug named “Tasigna” has been uncovered by Directorate of Post-Clearance Audit (DPCA).
According...
Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
Ferozsons strikes deal with Gilead Sciences to produce generic HIV drug
Ferozsons or its affiliates can manufacture and sell lenacapavir in 120 countries
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...
Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales
Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...